Compare COCO & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COCO | WVE |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.4B |
| IPO Year | 2021 | 2015 |
| Metric | COCO | WVE |
|---|---|---|
| Price | $53.77 | $12.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $58.13 | $31.47 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.60 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | N/A | ★ $3,704,000.00 |
| Revenue This Year | $16.12 | $0.34 |
| Revenue Next Year | $11.40 | $83.30 |
| P/E Ratio | $46.02 | ★ N/A |
| Revenue Growth | N/A | ★ 149.43 |
| 52 Week Low | $25.79 | $5.28 |
| 52 Week High | $61.39 | $21.73 |
| Indicator | COCO | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 43.18 |
| Support Level | $50.40 | $6.61 |
| Resistance Level | $55.43 | $14.50 |
| Average True Range (ATR) | 2.49 | 0.70 |
| MACD | -0.31 | -0.14 |
| Stochastic Oscillator | 32.98 | 31.57 |
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.